1074 2.5/1000 (Xigduo XR 2.5 mg / 1000 mg)
Generic Name: dapagliflozin/metformin
Pill with imprint 1074 2.5/1000 is Brown, Elliptical / Oval and has been identified as Xigduo XR 2.5 mg / 1000 mg. It is supplied by AstraZeneca.
Xigduo XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Xigduo XR 2.5 mg / 1000 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 1074 2.5/1000
Xigduo XR
- Generic Name
- dapagliflozin/metformin
- Imprint
- 1074 2.5/1000
- Strength
- 2.5 mg / 1000 mg
- Color
- Brown
- Size
- 20.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-6225
- Inactive Ingredients
-
microcrystalline cellulose, lactose anhydrous, silicon dioxide, magnesium stearate, hypromellose 2208 (100000 mPa.s), hypromellose 2910 (5 mPa.s)
Note: Inactive ingredients may vary.
More about Xigduo XR (dapagliflozin / metformin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 10 Reviews
- Drug class: antidiabetic combinations
- FDA Alerts (4)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
